Could a simple drug switch transform heart care in rural tanzania?

NCT ID NCT06704633

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether changing from standard heart failure medications to a newer drug (sacubitril-valsartan) can improve the health and daily life of people with heart failure in rural Tanzania. About 298 adults with heart failure will be switched to the new drug and followed for 10 months. The goal is to see if they feel better, can walk farther, and have fewer symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure systolic heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Heart and Lung Clinic, St Francis Regional Referral Hospital, Ifakara, Tanzania

    Ifakara, Morogoro, Tanzania

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••